Xerostomia (Dry Mouth Disease) Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Xerostomia (Dry Mouth Disease) Therapeutics Market size was estimated at USD 625.3 million in 2020 and is expected to grow at a CAGR of 3% during the forecast period 2022 to 2028.

Dry mouth, commonly referred to as dry mouth syndrome, is the result of a decrease or absence of salivary flow that causes dry mucous membranes. The increase in radiation therapy and chemotherapy is likely to lead to an increase in the incidence of dry mouth, which is estimated to drive the dry mouth treatment market. Other factors driving the market growth include increasing use of prescription drugs, ease of availability and cost-effectiveness of drugs, growing geriatric population base, and increasing prevalence of diseases such as Sjogren’s syndrome, HIV, diabetes and Alzheimer’s disease. Moreover, factors such as lack of awareness and lack of effective treatments are likely to hinder the use of dry mouth treatment products and may act as limiting factors for the dry mouth treatment market.

Market Segments

By Type

• Artificial Saliva
• Salivary Stimulants
• Saliva Substitutes
• Drugs
• Salivary Pens

Key Players

• Acacia Pharma
• Church & Dwight
• GlaxoSmithKline
• Hikma Pharmaceuticals
• Lupin
• OraCoat
• Parnell Pharmaceuticals
• Pendopharm
• Pfizer
• Sun Pharmaceutical Industries
• Synedgen

Scope of the Report

The research study analyzes the global Xerostomia (Dry Mouth Disease) Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Xerostomia (Dry Mouth Disease) Therapeutics Market Report

1. What was the Xerostomia (Dry Mouth Disease) Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Xerostomia (Dry Mouth Disease) Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Xerostomia (Dry Mouth Disease) Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.